Intervention

Insulin Aspart

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 29 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials29

Recruiting0

Common conditions13

Lead sponsors shown15

Clinical trials

29 shown

A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpNCT07068295 · 2025-07-11

Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 in Healthy SubjectsNCT05719961 · 2023-01-05

Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index MealNCT04019821 · 2020-01-01

Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes MellitusNCT04120623 · 2019-10-01

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.NCT04124302 · 2019-10-01

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 DiabetesNCT03659799 · 2019-04-12

Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineNCT03874715 · 2019-03-11

IDegLira HIGH TrialNCT03737240 · 2019-01-15

Simplified Insulin Regimen for the ElderlyNCT03660553 · 2018-10-10

Use of NPH Versus Basal Bolus Insulin for Steroid Induced HyperglycemiaNCT03511521 · 2018-03-27

A Meal Test Study of LY900014 in Participants With Type 1 Diabetes MellitusNCT03449433 · 2018-03-15

Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus PatientsNCT03430856 · 2017-12-26

Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes MellitusNCT03916601 · 2017-12-13

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesNCT03377699 · 2017-11-22

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes MellitusNCT02938572 · 2016-10-19

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusNCT02933853 · 2016-10-14

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin PumpNCT02546401 · 2015-09-01

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyNCT01966978 · 2014-11-01

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes MellitusNCT03202875 · 2012-11-14

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyNCT01474538 · 2011-12-01

Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 InhalerNCT01196104 · 2010-09-01

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial LipidsNCT01293396 · 2010-06-01

Collection of Information-Rich Type 1 Diabetes DataNCT01223560 · 2009-10-01

Memory and Insulin in Early Alzheimer's DiseaseNCT00581867 · 2007-10-01

Changes of the Infusion Rate in Insulin Pump TreatmentNCT00449839 · 2007-04-01

Bioavailability of Insulin Administered in DuodenumNCT00353990 · 2006-08-01

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.NCT00254085 · 2005-03-01

Comparison of Insulins Aspart and Lispro in Insulin PumpsNCT00461331 · 2004-10-01

South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes MellitusNCT00121966 · 2003-01-01

Common conditions

Diabetes6 Diabetes Mellitus, Type 15 Type 2 Diabetes Mellitus4 Diabetes Mellitus, Type 23 Type 1 Diabetes3 Type 1 Diabetes Mellitus3 Type 2 Diabetes3 Diabetes Mellitus2 Alzheimer's Disease1 Diabetes Type 11 Hyperglycemia Steroid-induced1 Insulin Resistance, Diabetes1 Type2 Diabetes Mellitus1

Leading sponsors

Novo Nordisk A/S4 Sanofi3 Eli Lilly and Company2 Medical University of Warsaw2 Aarhus University Hospital1 Biocon Limited1 Emory University1 Hvidovre University Hospital1 Institut de Recherches Cliniques de Montreal1 Jeff Burns, MD1 Jiangsu HengRui Medicine Co., Ltd.1 Mannkind Corporation1 Medical University of Graz1 Nanjing First Hospital, Nanjing Medical University1 Northwestern University1

Trial status mix

COMPLETED23

TERMINATED3

UNKNOWN3

Phase mix

PHASE412

PHASE19

PHASE37

PHASE23

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.